CN103006968A - Ointment for treating rheumatism - Google Patents
Ointment for treating rheumatism Download PDFInfo
- Publication number
- CN103006968A CN103006968A CN2012105360165A CN201210536016A CN103006968A CN 103006968 A CN103006968 A CN 103006968A CN 2012105360165 A CN2012105360165 A CN 2012105360165A CN 201210536016 A CN201210536016 A CN 201210536016A CN 103006968 A CN103006968 A CN 103006968A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- caulis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides ointment for treating rheumatism, comprising the following traditional Chinese medicine raw materials in parts by weight: 1-5 parts of scandent schefflera root, 1-5 parts of paris polyphylla, 16-20 parts of angelica sinensis, 16-20 parts of salvia miltiorrhiza, 19-23 parts of suberect spatholobus stem, 16-20 parts of kadsura pepper stem, 19-23 parts of garden balsam stem, 16-20 parts of schizophragma integrifolium, 16-20 parts of radix angelicae pubescentis, 19-23 parts of nutgrass galingale rhizome, 13-17 parts of cassia twig, 8-12 parts of asarum, 13-17 parts of radix achyranthis bidentatae, 13-17 parts of radix saposhnikoviae, 13-17 parts of notopterygium root, 13-17 parts of radix clematidis and 8-12 parts of monkshood. The traditional Chinese medicine raw materials are milled into fine powder and a blender is added to obtain the ointment. According to the ointment for treating the rheumatism, the traditional Chinese medicine raw materials are mixed according to the weight parts to sufficiently express the medicine effect of synergic treatment, so that the effects of relaxing muscles and tendons, dispelling wind and cold and removing moisture, excreting water and resuscitating, warming muscles and reliving pain, and dissipating blood stasis detumescence are achieved, and the symptoms of arthralgia, swelling, and difficulty to walk of patients can be solved.
Description
Technical field:
The present invention relates to medical technical field, particularly a kind ofly treat rheumatismal plaster.
Background technology:
Arthromyodynia is with muscle muscles and bones, joint aches, numbness, joint stuffiness, in addition arthroncus scorching hot be the symptom of main clinical manifestation.It comprises the diseases such as rheumatic arthritis in the modern medicine, rheumatoid arthritis osteoneuralgia.
[0003] present, the medicine of disclosed treatment of arthritis is more, and wherein mainly take oral medicine as main, such as hormones analgesic and the Chinese patent medicine that contains toxic component, they have obvious side effect more, can not take for a long time.
Summary of the invention:
In view of this, be necessary to provide a kind of rheumatismal plaster for the treatment of.
[0005] a kind ofly treats rheumatismal plaster, the raw material of Chinese medicine that comprises following parts by weight: 1 part ~ 5 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 1 part ~ 5 parts of Rhizoma Paridis, 16 parts ~ 20 parts of Radix Angelicae Sinensis, 16 parts ~ 20 parts of Radix Salviae Miltiorrhizaes, 19 parts ~ 23 parts of Caulis Spatholobis, 16 parts ~ 20 parts of Caulis Piperis Kadsuraes, 19 parts ~ 23 parts of Herba speranskiae tuberculataes, 16 parts ~ 20 parts of Cortex schizophragmatis integrifolii radiciss, 16 parts ~ 20 parts of Radix Angelicae Pubescentiss, 19 parts ~ 23 parts of Rhizoma Cyperis, 13 parts ~ 17 parts of Ramulus Cinnamomi, 8 parts ~ 12 parts of Herba Asaris, 13 parts ~ 17 parts of Radix Achyranthis Bidentataes, 13 parts ~ 17 parts of Radix Saposhnikoviaes, 13 parts ~ 17 parts of Rhizoma Et Radix Notopterygiis, 13 parts ~ 17 parts of Radix Clematidis, 8 parts ~ 12 parts of Radix Aconitis, after above-mentioned raw material of Chinese medicine ground to the powder with blender to obtain plaster.
[0006] inventor is according to the plaster prescription for the treatment of for many years the rheumatismal above-mentioned Chinese medicine composition of summarizing the experience out, with Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Rhizoma Paridis, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Caulis Spatholobi, Caulis Piperis Kadsurae, Herba speranskiae tuberculatae, Cortex schizophragmatis integrifolii radicis, Radix Angelicae Pubescentis, Rhizoma Cyperi, Ramulus Cinnamomi, Herba Asari, Radix Achyranthis Bidentatae, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Radix Clematidis, Radix Aconiti is as raw material of Chinese medicine, simultaneously above-mentioned raw material of Chinese medicine is given full play of the drug effect of Synergistic treatment according to above-mentioned parts by weight proportioning, give full play to channels sootheing and network vessel quickening, functions dispelling wind and clearing away cold, removing dampness, row water is had one's ideas straightened out, the pain relieving of temperature muscle, the effect of detumescence dissipating blood stasis solves rheumatisant's arthralgia by the external application affected part, swelling, the symptom of difficulty in walking.
The specific embodiment:
The inventor is according to treating for many years the rheumatismal plaster prescription of the rheumatismal above-mentioned treatment of summarizing the experience out.
[0008] a kind ofly treats rheumatismal plaster, the raw material of Chinese medicine that comprises following parts by weight: 1 part ~ 5 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 1 part ~ 5 parts of Rhizoma Paridis, 16 parts ~ 20 parts of Radix Angelicae Sinensis, 16 parts ~ 20 parts of Radix Salviae Miltiorrhizaes, 19 parts ~ 23 parts of Caulis Spatholobis, 16 parts ~ 20 parts of Caulis Piperis Kadsuraes, 19 parts ~ 23 parts of Herba speranskiae tuberculataes, 16 parts ~ 20 parts of Cortex schizophragmatis integrifolii radiciss, 16 parts ~ 20 parts of Radix Angelicae Pubescentiss, 19 parts ~ 23 parts of Rhizoma Cyperis, 13 parts ~ 17 parts of Ramulus Cinnamomi, 8 parts ~ 12 parts of Herba Asaris, 13 parts ~ 17 parts of Radix Achyranthis Bidentataes, 13 parts ~ 17 parts of Radix Saposhnikoviaes, 13 parts ~ 17 parts of Rhizoma Et Radix Notopterygiis, 13 parts ~ 17 parts of Radix Clematidis, 8 parts ~ 12 parts of Radix Aconitis, with above-mentioned raw material of Chinese medicine rear mistake 120 mesh sieves that grind to the powder, with blender to obtain plaster.Above-mentioned umber can represent with g.Wherein, blender can be a kind of in tea, Mel, Oleum Sesami, the Chinese liquor.Above-mentioned every umber can represent with 1g.In other embodiments, this is treated rheumatismal plaster and can adopt existing Chinese medicine patcher manufacturing process to make bar cloth cream.
The concrete gravimetric value (wherein, every part is 1g) of the raw material of Chinese medicine of the rheumatismal plaster of above-mentioned treatment is described [0009] for example:
Prescription one: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1 g, Rhizoma Paridis 1 g, Radix Angelicae Sinensis 16 g, Radix Salviae Miltiorrhizae 16 g, Caulis Spatholobi 19 g, Caulis Piperis Kadsurae 16 g, Herba speranskiae tuberculatae 19 g, Cortex schizophragmatis integrifolii radicis 16 g, Radix Angelicae Pubescentis 16 g, Rhizoma Cyperi 19 g, Ramulus Cinnamomi 13 g, Herba Asari 8 g, Radix Achyranthis Bidentatae 13 g, Radix Saposhnikoviae 13 g, Rhizoma Et Radix Notopterygii 13 g, Radix Clematidis 13 g, Radix Aconiti 8 g.
[0010] prescription two: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 3 g, Rhizoma Paridis 3 g, Radix Angelicae Sinensis 18 g, Radix Salviae Miltiorrhizae 18 g, Caulis Spatholobi 21 g, Caulis Piperis Kadsurae 18 g, Herba speranskiae tuberculatae 21 g, Cortex schizophragmatis integrifolii radicis 18 g, Radix Angelicae Pubescentis 18 g, Rhizoma Cyperi 21g, Ramulus Cinnamomi 15 g, Herba Asari 10 g, Radix Achyranthis Bidentatae 15 g, Radix Saposhnikoviae 15 g, Rhizoma Et Radix Notopterygii 15 g, Radix Clematidis 15 g, Radix Aconiti 10 g.
[0011] prescription three: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 5 g, Rhizoma Paridis 5 g, Radix Angelicae Sinensis 20 g, Radix Salviae Miltiorrhizae 20 g, Caulis Spatholobi 23 g, Caulis Piperis Kadsurae 20 g, Herba speranskiae tuberculatae 23 g, Cortex schizophragmatis integrifolii radicis 20 g, Radix Angelicae Pubescentis 20 g, Rhizoma Cyperi 23 g, Ramulus Cinnamomi 17 g, Herba Asari 12 g, Radix Achyranthis Bidentatae 17 g, Radix Saposhnikoviae 17 g, Rhizoma Et Radix Notopterygii 17 g, Radix Clematidis 17 g, Radix Aconiti 12 g.
[0012] be the rheumatismal plaster clinical application effect explanation of above-mentioned treatment below:
This organizes 50 examples, and the oldest 65 years old, minimum 15 years old, male's 12 examples wherein, women's 38 examples
Diagnostic criteria: be symmetry pain from the beginning of little joint, swelling, morning is stiff, and is movable unfavorable, plays pain slowly, repeatedly, the disease joint of getting involved for a long time is prismatic swelling, tenderness, tenderness, later stage joint deformity, stiff, show smooth, amyotrophy on every side, the heavy rheumatoid factor of having a blood test is positive.
[0013] treatment: use the rheumatismal plaster of above-mentioned treatment to treat.
[0014] criterion of therapeutical effect: cure, arthralgia, movable function is normal, and the test chamber inspection is normal; Take a turn for the better, arthralgia, swelling alleviates, and movable function improves, and lab testing is improved; Do not heal: arthralgia, swelling and test chamber check unchanged.
[0015] therapeutic outcome; This organizes 50 examples, clinical cure 34 examples, 14 examples that take a turn for the better, 2 examples that do not heal, total effective rate 96%
Sum up: rheumatoid arthritis belongs to the impediment syndrome category, modern medicine is thought primary disease and immunoinfective, the factors such as allergy are relevant, pathogenesis is bright so far, at present to this without specific short, doctor trained in Western medicine benefit rheumatism, pain relieving, hormones makes the symptom respite, Yunqi's curative effect can not be consolidated, the traditional Chinese medical science thinks that primary disease is many by the damp and hot heresy of affection of exogenous wind-cold, so that pathogen invades human body multiple abscess muscle, joint meridians and falling ill, meridians are impaired, the QI and blood retardance, stagnation of QI and blood may bring about pain, Radix Angelicae Sinensis in the rheumatismal plaster of above-mentioned treatment, Radix Salviae Miltiorrhizae, the Caulis Spatholobi nourishing blood and promoting blood circulation, the arthralgia aggravated by cold of dispeling the wind, the Rhizoma Cyperi qi and blood circulation promotion, Caulis Piperis Kadsurae, Herba speranskiae tuberculatae, Cortex schizophragmatis integrifolii radicis, Radix Angelicae Pubescentis, Radix Saposhnikoviae, Radix Clematidis, the notopterygium wind dispelling dehumidifying, the cold expelling channels sootheing and network vessel quickening, careful expelling wind and cold, row water, have one's ideas straightened out the Radix Aconiti expelling wind and removing dampness, the pain relieving of temperature muscle, above raw material of Chinese medicine gives full play of the drug effect of Synergistic treatment according to above-mentioned parts by weight proportioning, that is reach dredging the meridian, promoting flow of QI and blood, the effect of wind-expelling pain-stopping except dark evil numbness.This plaster of external application can vigorous function, and enhancing antibody forms, and with enhancing body defence and immunologic function, can strengthen the absorption to pathological products such as inflammation edema, reaches the purpose of anti-inflammatory analgesic, and this cream specimen is firm, and is respond well.
Claims (4)
1. treat rheumatismal plaster for one kind, it is characterized in that: the raw material of Chinese medicine that comprises following parts by weight: 1 part ~ 5 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 1 part ~ 5 parts of Rhizoma Paridis, 16 parts ~ 20 parts of Radix Angelicae Sinensis, 16 parts ~ 20 parts of Radix Salviae Miltiorrhizaes, 19 parts ~ 23 parts of Caulis Spatholobis, 16 parts ~ 20 parts of Caulis Piperis Kadsuraes, 19 parts ~ 23 parts of Herba speranskiae tuberculataes, 16 parts ~ 20 parts of Cortex schizophragmatis integrifolii radiciss, 16 parts ~ 20 parts of Radix Angelicae Pubescentiss, 19 parts ~ 23 parts of Rhizoma Cyperis, 13 parts ~ 17 parts of Ramulus Cinnamomi, 8 parts ~ 12 parts of Herba Asaris, 13 parts ~ 17 parts of Radix Achyranthis Bidentataes, 13 parts ~ 17 parts of Radix Saposhnikoviaes, 13 parts ~ 17 parts of Rhizoma Et Radix Notopterygiis, 13 parts ~ 17 parts of Radix Clematidis, 8 parts ~ 12 parts of Radix Aconitis, after above-mentioned raw material of Chinese medicine ground to the powder with blender to obtain plaster.
2. the rheumatismal plaster for the treatment of according to claim 1, it is characterized in that: the every umber of above-mentioned raw material of Chinese medicine represents with 1g, and above-mentioned raw material of Chinese medicine is specially: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1 g, Rhizoma Paridis 1 g, Radix Angelicae Sinensis 16 g, Radix Salviae Miltiorrhizae 16 g, Caulis Spatholobi 19 g, Caulis Piperis Kadsurae 16 g, Herba speranskiae tuberculatae 19 g, Cortex schizophragmatis integrifolii radicis 16 g, Radix Angelicae Pubescentis 16 g, Rhizoma Cyperi 19 g, Ramulus Cinnamomi 13 g, Herba Asari 8 g, Radix Achyranthis Bidentatae 13 g, Radix Saposhnikoviae 13 g, Rhizoma Et Radix Notopterygii 13 g, Radix Clematidis 13 g, Radix Aconiti 8 g.
3. the rheumatismal plaster for the treatment of according to claim 1, it is characterized in that: the every umber of above-mentioned raw material of Chinese medicine represents with 1g, and above-mentioned raw material of Chinese medicine is specially: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 3 g, Rhizoma Paridis 3 g, Radix Angelicae Sinensis 18 g, Radix Salviae Miltiorrhizae 18 g, Caulis Spatholobi 21 g, Caulis Piperis Kadsurae 18 g, Herba speranskiae tuberculatae 21 g, Cortex schizophragmatis integrifolii radicis 18 g, Radix Angelicae Pubescentis 18 g, Rhizoma Cyperi 21g, Ramulus Cinnamomi 15 g, Herba Asari 10 g, Radix Achyranthis Bidentatae 15 g, Radix Saposhnikoviae 15 g, Rhizoma Et Radix Notopterygii 15 g, Radix Clematidis 15 g, Radix Aconiti 10 g.
4. the rheumatismal plaster for the treatment of according to claim 1, it is characterized in that: the every umber of above-mentioned raw material of Chinese medicine represents with 1g, and above-mentioned raw material of Chinese medicine is specially: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 5 g, Rhizoma Paridis 5 g, Radix Angelicae Sinensis 20 g, Radix Salviae Miltiorrhizae 20 g, Caulis Spatholobi 23 g, Caulis Piperis Kadsurae 20 g, Herba speranskiae tuberculatae 23 g, Cortex schizophragmatis integrifolii radicis 20 g, Radix Angelicae Pubescentis 20 g, Rhizoma Cyperi 23 g, Ramulus Cinnamomi 17 g, Herba Asari 12 g, Radix Achyranthis Bidentatae 17 g, Radix Saposhnikoviae 17 g, Rhizoma Et Radix Notopterygii 17 g, Radix Clematidis 17 g, Radix Aconiti 12 g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105360165A CN103006968A (en) | 2012-12-13 | 2012-12-13 | Ointment for treating rheumatism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105360165A CN103006968A (en) | 2012-12-13 | 2012-12-13 | Ointment for treating rheumatism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103006968A true CN103006968A (en) | 2013-04-03 |
Family
ID=47956431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105360165A Pending CN103006968A (en) | 2012-12-13 | 2012-12-13 | Ointment for treating rheumatism |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103006968A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104474121A (en) * | 2014-11-14 | 2015-04-01 | 陶玲云 | Rheumatism treatment medicine |
| CN104623081A (en) * | 2015-01-13 | 2015-05-20 | 贵州奢香药业有限公司 | Collateral-dredging pain relieving film |
| CN105213987A (en) * | 2015-10-30 | 2016-01-06 | 刘娜 | A kind of Chinese medicinal tablet for the treatment of internal medicine arthromyodynia |
| CN115089631A (en) * | 2021-10-22 | 2022-09-23 | 赵利国 | Liquid medicine for treating rheumatic arthritis for people with high blood pressure, high blood sugar and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1375298A (en) * | 2001-01-04 | 2002-10-23 | 黄兆元 | Pain-relieving notoginseng mixture |
| CN1555880A (en) * | 2004-01-06 | 2004-12-22 | 梁兴涛 | Knoks and falls bone connecting plaster preparation method |
-
2012
- 2012-12-13 CN CN2012105360165A patent/CN103006968A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1375298A (en) * | 2001-01-04 | 2002-10-23 | 黄兆元 | Pain-relieving notoginseng mixture |
| CN1555880A (en) * | 2004-01-06 | 2004-12-22 | 梁兴涛 | Knoks and falls bone connecting plaster preparation method |
Non-Patent Citations (3)
| Title |
|---|
| 李正红等: "中医熏洗法在骨伤科中的运用研究进展", 《中医外治杂志》 * |
| 樊冰: "中医药治疗类风湿性关节炎进展", 《山东中医药大学学报》 * |
| 郭中琦等: "类风湿性关节炎中医药治疗进展", 《临床荟萃》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104474121A (en) * | 2014-11-14 | 2015-04-01 | 陶玲云 | Rheumatism treatment medicine |
| CN104623081A (en) * | 2015-01-13 | 2015-05-20 | 贵州奢香药业有限公司 | Collateral-dredging pain relieving film |
| CN105213987A (en) * | 2015-10-30 | 2016-01-06 | 刘娜 | A kind of Chinese medicinal tablet for the treatment of internal medicine arthromyodynia |
| CN115089631A (en) * | 2021-10-22 | 2022-09-23 | 赵利国 | Liquid medicine for treating rheumatic arthritis for people with high blood pressure, high blood sugar and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101288728B (en) | Plaster for treating rheumatism, rheumatoid, a variety of hyperosteogenys | |
| CN100376229C (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN103272096A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
| CN103006968A (en) | Ointment for treating rheumatism | |
| CN101129675B (en) | Externally used plaster for treating rheumatism and kind of rheumatism | |
| CN103860801A (en) | Plaster with capability of relaxing muscles and stimulating blood circulation and preparation method of plaster | |
| CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN101040949B (en) | Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application | |
| CN102188595A (en) | Chinese medicine composition for treating arthritis and preparation method thereof | |
| CN100423744C (en) | Medication for treating hyperosteogeny and complicating disease | |
| CN111840398A (en) | External application traditional Chinese medicine capable of effectively treating neck, shoulder, waist and leg pain | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN102309560A (en) | Chinese medicinal decoction for treating rheumatic arthritis | |
| CN104383166A (en) | Medicine for treating rheumatic lumbocrural pains and preparation method thereof | |
| CN104306606A (en) | A traditional Chinese medicine preparation for treating osteoarthritis and a preparing method thereof | |
| CN101099848A (en) | Traditional Chinese medicine powder agent for treating rheumatic arthritis, rheumatoid arthritis and ostealgia | |
| CN101468096A (en) | Chinese medicinal composition for treating skin disease | |
| CN103721018A (en) | External traditional Chinese medicinal tincture for treating arthritis | |
| CN101138625A (en) | Chinese medicine composition for treating omarthritis | |
| CN103330798A (en) | Traditional Chinese medicinal preparation for treating rheumatisms | |
| CN103285105B (en) | Traditional Chinese medicine for treating sciatica and preparation method thereof | |
| CN104721427A (en) | Traditional Chinese medicine preparation for treating rheumatic bone diseases | |
| CN101530598B (en) | Plaster used for hyperosteogeny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130403 |